SCHEMBL7402271

SCHEMBL7402271

C=Cc1nc2[nH]c(=O)[nH]c(=O)c2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.48
▸ ADORA2B P29275 2/20 0.45
▸ GDA Q9Y2T3 2/20 0.40
▸ ACHE P22303 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ XDH P47989 7/20 0.36
▸ RPS6KA3 P51812 1/20 0.34
▸ BLM P54132 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ DPYD Q12882 1/20 0.33
▸ PABPC1 P11940 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992130 0.74 MAPT (0.42) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL5173509 0.73 MAPT (0.44) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL561427 0.72 ADORA2B (0.55) ADORA2BALDH1A1HPGDMAPK1XDH
SCHEMBL2143500 0.70 MAPT (0.46) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL2837685 0.69 MAPT (0.53) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL932949 0.69 MAPT (0.53) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL447389 0.69 MAPT (0.84) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL932609 0.69 MAPT (0.53) MAPTADORA2BGDAACHEALDH1A1
SCHEMBL740931 0.69 MAPT (0.53) MAPTADORA2BGDAACHEALDH1A1
Uric Acid SCHEMBL2786719 0.69 MAPT (0.53) MAPTADORA2BGDAACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861405-A A2-SELECTIVE ADENOSINE RECEPTOR ANTAGONIST AS ANTIDEPRESSANTS AND CNS STIMULANTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-01-19 — — US disclosed
WO-1994025462-A1 8-SUBSTITUTED 1,3,7-TRIALKYL-XANTHINE DERIVATIVES AS A2-SELECTIVE ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY THE (US) 1994-11-10 — — WO disclosed
Send feedback